Endocrine treatment versus chemotherapy in postmenopausal women with hormone receptor-positive, HER2-negative, metastatic breast cancer: a systematic review and network meta-analysis
Mario Giuliano(University of Naples Federico II), Francesco Schettini(University of Naples Federico II), Carla Rognoni(Bocconi University), Manuela Milani(Istituti Ospitalieri di Cremona), Guy Jérusalem(Centre Hospitalier Universitaire de Liège), Thomas Bachelot(Centre de Recherche en Cancérologie de Lyon), Michelino De Laurentiis(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Guglielmo Thomas(Clinica Mediterranea), Pietro De Placido(University of Naples Federico II), Grazia Arpino(University of Naples Federico II), Sabino De Placido(University of Naples Federico II), Massimo Cristofanilli(Northwestern University), Antonio Giordano(Medical University of South Carolina), Fabio Puglisi(Centro di Riferimento Oncologico), Barbara Pistilli(Institut Gustave Roussy), Aleix Prat(Hospital Clínic de Barcelona), Lucia Del Mastro(University of Genoa), Sergio Venturini(University of Turin), Daniele Generali(Istituti Ospitalieri di Cremona)
Cited by 192Open Access